No reason to cheer India drug verdict

Article Highlights

  • The is no guarantee that Indian companies can reproduce a drug that is as safe or effective as Gleevec

    Tweet This

  • The Indian Supreme Court dissuades foreign investment from working with Indian drug companies to improve drug quality

    Tweet This

  • Increasing access to medicines of uncertain quality is hardly a victory for public health

    Tweet This

The Indian Supreme Court’s decision on Gleevec will surely help some patients seeking affordable treatment (“US should tighten rules for patenting changes to drugs,” Editorial, April 8), but there is no guarantee that local companies can reproduce a drug that is as safe or effective as the original, especially when they have no data-sharing agreement with the company that designed it.

Quality assurance depends on India’s drug regulator, which is plagued with problems; a parliamentary report last year accused the agency of extensive corruption and misrepresentation of pharmaceutical drug data.

Foreign investments in India are one of the strongest tools to counteract these corrupt forces — by working hand-in-glove with Indian pharmaceutical companies and government agencies to improve oversight, information-sharing, management, and product quality. The court’s decision will discourage these investments.

That should be a concern for anyone celebrating the Gleevec decision. Increasing access to medicines of uncertain quality is hardly a victory for public health.

Dr. Roger Bate is a scholar at the American Enterprise Institute.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate

What's new on AEI

AEI Election Watch 2014: What will happen and why it matters
image A nation divided by marriage
image Teaching reform
image Socialist party pushing $20 minimum wage defends $13-an-hour job listing
AEI on Facebook
Events Calendar
  • 20
    MON
  • 21
    TUE
  • 22
    WED
  • 23
    THU
  • 24
    FRI
Monday, October 20, 2014 | 2:00 p.m. – 3:30 p.m.
Warfare beneath the waves: The undersea domain in Asia

We welcome you to join us for a panel discussion of the undersea military competition occurring in Asia and what it means for the United States and its allies.

Tuesday, October 21, 2014 | 8:30 a.m. – 10:00 a.m.
AEI Election Watch 2014: What will happen and why it matters

AEI’s Election Watch is back! Please join us for two sessions of the longest-running election program in Washington, DC. 

Wednesday, October 22, 2014 | 1:00 p.m. – 2:30 p.m.
What now for the Common Core?

We welcome you to join us at AEI for a discussion of what’s next for the Common Core.

Thursday, October 23, 2014 | 10:00 a.m. – 11:00 a.m.
Brazil’s presidential election: Real challenges, real choices

Please join AEI for a discussion examining each candidate’s platform and prospects for victory and the impact that a possible shift toward free-market policies in Brazil might have on South America as a whole.

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.